NO934774L - Antiretroviral hydrazine derivatives - Google Patents
Antiretroviral hydrazine derivativesInfo
- Publication number
- NO934774L NO934774L NO934774A NO934774A NO934774L NO 934774 L NO934774 L NO 934774L NO 934774 A NO934774 A NO 934774A NO 934774 A NO934774 A NO 934774A NO 934774 L NO934774 L NO 934774L
- Authority
- NO
- Norway
- Prior art keywords
- unsubstituted
- substituted alkyl
- denotes
- substituted
- aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C281/02—Compounds containing any of the groups, e.g. carbazates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/10—Hydrazines
- C07C243/12—Hydrazines having nitrogen atoms of hydrazine groups bound to acyclic carbon atoms
- C07C243/14—Hydrazines having nitrogen atoms of hydrazine groups bound to acyclic carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
- C07C243/26—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C243/34—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a carbon skeleton further substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Curing Cements, Concrete, And Artificial Stone (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Paints Or Removers (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Indole Compounds (AREA)
- Quinoline Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Epoxy Compounds (AREA)
Abstract
Compounds of the formula <IMAGE> in which R1 and R9, independently of each other, denote hydrogen, acyl or unsubstituted or substituted alkyl; sulpho; or sulphonyl which is substituted by unsubstituted or substituted alkyl, aryl or heterocyclyl, with the proviso that at most one of the radicals R1 and R9 denotes hydrogen; and R2 and R8, in each case independently of each other, denote hydrogen or unsubstituted or substituted alkyl; R3 and R4, independently of each other, denote hydrogen, unsubstituted or substituted alkyl, unsubstituted or substituted cycloalkyl or aryl; R5 denotes acyloxy; R6 denotes hydrogen; and R7 denotes unsubstituted or substituted alkyl, unsubstituted or substituted cycloalkyl or aryl; are described, as are salts of the said compounds, insofar as salt-forming groups are present; these compounds exhibit anti-retroviral activity.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH394292 | 1992-12-23 |
Publications (4)
Publication Number | Publication Date |
---|---|
NO934774D0 NO934774D0 (en) | 1993-12-22 |
NO934774L true NO934774L (en) | 1994-06-24 |
NO180442B NO180442B (en) | 1997-01-13 |
NO180442C NO180442C (en) | 1997-04-23 |
Family
ID=4266802
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO934774A NO180442C (en) | 1992-12-23 | 1993-12-22 | Antiretroviral hydrazine derivatives |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0604368B1 (en) |
JP (1) | JPH06279386A (en) |
KR (1) | KR940014306A (en) |
CN (1) | CN1093701A (en) |
AT (1) | ATE143004T1 (en) |
AU (1) | AU672448B2 (en) |
CA (1) | CA2112047A1 (en) |
CZ (1) | CZ285793A3 (en) |
DE (1) | DE59303870D1 (en) |
DK (1) | DK0604368T3 (en) |
ES (1) | ES2093394T3 (en) |
FI (1) | FI935753A (en) |
GR (1) | GR3021263T3 (en) |
HU (1) | HUT66494A (en) |
IL (1) | IL108113A0 (en) |
MA (1) | MA23068A1 (en) |
NO (1) | NO180442C (en) |
NZ (1) | NZ250535A (en) |
PL (1) | PL301611A1 (en) |
SK (1) | SK145993A3 (en) |
ZA (1) | ZA939610B (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5888992A (en) | 1992-03-11 | 1999-03-30 | Narhex Limited | Polar substituted hydrocarbons |
DE69333270T2 (en) | 1992-03-11 | 2004-08-05 | Narhex Ltd. | AMINE DERIVATIVES OF OXO AND HYDROXY SUBSTITUTED CARBON HYDROGEN |
US6071895A (en) | 1992-03-11 | 2000-06-06 | Narhex Limited | Polar-substituted hydrocarbons |
RU2126794C1 (en) | 1992-03-11 | 1999-02-27 | Нархекс Лимитед | Amino-derivatives of oxo- or hydroxy-substituted hydrazines, method of their synthesis and pharmaceutical compositions for inhibition of retrovirus protease |
WO1996005180A1 (en) * | 1994-08-09 | 1996-02-22 | Abbott Laboratories | Retroviral protease inhibiting 1,2,4-triazacycloheptanes |
WO1996028423A1 (en) * | 1995-03-15 | 1996-09-19 | Sankyo Company, Limited | Dipeptide compounds having ahpba structure |
WO1997019055A1 (en) * | 1995-11-21 | 1997-05-29 | Novartis Ag | Azahexane derivatives as substrate isosters of retroviral asparate proteases |
TW409125B (en) * | 1996-04-22 | 2000-10-21 | Novartis Ag | Antivirally active heterocyclic azahexane derivatives |
US5849911A (en) | 1996-04-22 | 1998-12-15 | Novartis Finance Corporation | Antivirally active heterocyclic azahexane derivatives |
DE69710731T2 (en) * | 1996-07-17 | 2002-10-24 | Novartis Ag | ANILINOPEPTID DERIVATIVES |
ES2378669T3 (en) * | 2003-12-11 | 2012-04-16 | Abbott Laboratories | HIV protease inhibitor compounds |
NZ573887A (en) | 2006-07-21 | 2012-02-24 | Gilead Sciences Inc | Antiviral protease inhibitors |
JP5372751B2 (en) * | 2006-07-21 | 2013-12-18 | ギリアード サイエンシーズ, インコーポレイテッド | AZA-peptide protease inhibitor |
JOP20180009A1 (en) | 2017-02-06 | 2019-01-30 | Gilead Sciences Inc | Hiv inhibitor compounds |
TWI766172B (en) | 2018-07-30 | 2022-06-01 | 美商基利科學股份有限公司 | Anti-hiv compounds |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE635585A (en) * | 1962-07-30 | |||
US5142056A (en) | 1989-05-23 | 1992-08-25 | Abbott Laboratories | Retroviral protease inhibiting compounds |
US4794109A (en) | 1982-11-16 | 1988-12-27 | Ciba-Geigy Corporation | 6-hydroxy-lower alkylpenem compounds, pharmaceutical preparations that contain these compounds, and the use of the latter |
EP0236734A3 (en) | 1986-02-07 | 1988-05-11 | Ciba-Geigy Ag | 5-Amino-4-hydroxyvaleryl derivatives substituted by s-containing groups |
HU9301446D0 (en) * | 1990-11-19 | 1993-11-29 | Monsanto Co | Inhibitors or fetrovirus protease |
CA2057369A1 (en) * | 1990-12-17 | 1992-06-18 | Ann E. Decamp | Stereocontrolled production of hydroxyester, hydroxyamide, and lactone compounds from chiral alpha-amino aldehydes |
ES2093237T3 (en) | 1991-07-03 | 1996-12-16 | Ciba Geigy Ag | DERIVATIVES OF HYDRAZINE PHARMACOLOGICALLY ACTIVE AND PROCEDURE FOR THEIR OBTAINING. |
EP0532466A3 (en) | 1991-09-12 | 1993-06-16 | Ciba-Geigy Ag | Derivatives of 5-amino-4-hydroxy-hexanoic acid and their therapeutical use |
RU2126794C1 (en) * | 1992-03-11 | 1999-02-27 | Нархекс Лимитед | Amino-derivatives of oxo- or hydroxy-substituted hydrazines, method of their synthesis and pharmaceutical compositions for inhibition of retrovirus protease |
AU681342B2 (en) * | 1992-03-11 | 1997-08-28 | Narhex Limited | Amine derivatives of oxo- and hydroxy-substitued hydrocarbons |
-
1993
- 1993-12-14 AT AT93810879T patent/ATE143004T1/en not_active IP Right Cessation
- 1993-12-14 EP EP93810879A patent/EP0604368B1/en not_active Expired - Lifetime
- 1993-12-14 ES ES93810879T patent/ES2093394T3/en not_active Expired - Lifetime
- 1993-12-14 DE DE59303870T patent/DE59303870D1/en not_active Expired - Fee Related
- 1993-12-14 DK DK93810879.2T patent/DK0604368T3/da active
- 1993-12-17 AU AU52479/93A patent/AU672448B2/en not_active Ceased
- 1993-12-20 FI FI935753A patent/FI935753A/en not_active Application Discontinuation
- 1993-12-21 CZ CZ932857A patent/CZ285793A3/en unknown
- 1993-12-21 CA CA002112047A patent/CA2112047A1/en not_active Abandoned
- 1993-12-21 IL IL10811393A patent/IL108113A0/en unknown
- 1993-12-21 SK SK1459-93A patent/SK145993A3/en unknown
- 1993-12-21 NZ NZ250535A patent/NZ250535A/en unknown
- 1993-12-22 PL PL93301611A patent/PL301611A1/en unknown
- 1993-12-22 NO NO934774A patent/NO180442C/en unknown
- 1993-12-22 ZA ZA939610A patent/ZA939610B/en unknown
- 1993-12-22 JP JP5324735A patent/JPH06279386A/en active Pending
- 1993-12-22 HU HU9303722A patent/HUT66494A/en unknown
- 1993-12-22 CN CN93112990A patent/CN1093701A/en active Pending
- 1993-12-23 MA MA23378A patent/MA23068A1/en unknown
- 1993-12-23 KR KR1019930029242A patent/KR940014306A/en not_active Application Discontinuation
-
1996
- 1996-10-04 GR GR960402614T patent/GR3021263T3/en unknown
Also Published As
Publication number | Publication date |
---|---|
DK0604368T3 (en) | 1997-02-24 |
NZ250535A (en) | 1995-11-27 |
PL301611A1 (en) | 1994-06-27 |
NO180442C (en) | 1997-04-23 |
SK145993A3 (en) | 1994-08-10 |
CN1093701A (en) | 1994-10-19 |
EP0604368B1 (en) | 1996-09-18 |
KR940014306A (en) | 1994-07-18 |
CZ285793A3 (en) | 1994-07-13 |
FI935753A (en) | 1994-06-24 |
HU9303722D0 (en) | 1994-04-28 |
CA2112047A1 (en) | 1994-06-24 |
ZA939610B (en) | 1994-06-23 |
JPH06279386A (en) | 1994-10-04 |
EP0604368A1 (en) | 1994-06-29 |
FI935753A0 (en) | 1993-12-20 |
HUT66494A (en) | 1994-11-28 |
AU5247993A (en) | 1994-07-07 |
AU672448B2 (en) | 1996-10-03 |
ATE143004T1 (en) | 1996-10-15 |
IL108113A0 (en) | 1994-04-12 |
NO180442B (en) | 1997-01-13 |
GR3021263T3 (en) | 1997-01-31 |
MA23068A1 (en) | 1994-07-01 |
NO934774D0 (en) | 1993-12-22 |
ES2093394T3 (en) | 1996-12-16 |
DE59303870D1 (en) | 1996-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE143004T1 (en) | ANTIRETROVIRAL HYDRAZINE DERIVATIVES | |
NO178541C (en) | Pharmacologically active hydrazine derivatives | |
ES2086094T3 (en) | NEW ALKYLAMINO-MERCAPTOALKYLAMIDES OR ONE OF THEIR COSMETICALLY ACCEPTABLE SALTS, AND THEIR USE AS REDUCING AGENTS, IN A PERMANENT DEFORMATION PROCEDURE OF THE HAIR. | |
ES2070186T3 (en) | NEW DERIVATIVES OF 2,4-DIAMINO-PIRIMIDINA-3-OXIDO AND ITS USE IN THE PREVENTION OF HAIR LOSS. | |
CO4520230A1 (en) | DERIVATIVES OF [3- (4-PHENYLPIPERACIN-1-IL) PROPYLAMINE, UNCLE AND OXYL] -PIRIDINE, PYRIMIDINE AND BENZENE AS ALPHA ANTAGONISTS 1- ADRENOCEPTORS | |
TR21666A (en) | 1-CARBONYL 1 PHENOXIFENYL 2 AZOLYLETHANOL TUEREVES WITH MICROBICIDES | |
ES2121183T3 (en) | SELECTIVE LINKS OF 5HT1D-5HT1B RECEPTORS DERIVED FROM INDOL-PIPERACINE USEFUL AS MEDICINES. | |
FI864618A (en) | NYA 3-OXADIAZOLE-OCH 3-CARBOXYLSYRA- CARBOLIN DERIVATIVES, DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM LAEKEMEDEL. | |
FI834730A0 (en) | 1-CARBOXYKANOYLPERHYDRO-INDOL-2-CARBOXYLSYROR OR DERIVATIVES | |
ATE164592T1 (en) | ANTIRETROVIRAL ACYL COMPOUNDS | |
AR246120A1 (en) | Five-membered heterocyclic derivatives of n'-substituted-n,n'- diacylhydrazines | |
FI865234A (en) | 5-AMINOALKYL- CARBOLINDERIVAT, DERAS FRAMSTAELLNING OCH ANVAENDNING SOM LAEKEMEDEL. | |
FI860145A (en) | HERBICIDER AV TYPE N- (PHOSPHONOMETHYLGYCYL) SULPHONYLAMINER. | |
AR007463A1 (en) | MONOAZOIC DYES REPLACED BY HALOALKYL CARBAMATE AND SULFONYL FLUORIDE GROUPS | |
RU93056850A (en) | ANTIRETROVIRAL HYDRAZINE DERIVATIVES |